Ledger.Open graph →
SEC Form D · Amendment · filed April 3, 2023

GLO Pharma, Inc

Offering
$42.5M
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Carlsbad, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Lauren Otsuki · Carlsbad, CAExec · DirectorScott Glenn · Carlsbad, CADirectorMarla Beck · Carlsbad, CADirectorVimla Black-Gupta · Carlsbad, CAExec · DirectorNicole Quinn · Carlsbad, CADirectorDayna Quanbeck · Carlsbad, CADirectorVincent P. Corso Iii · New Orleans, LAExec · DirectorJeff Stinson · Little Rock, ARDirectorDan Dearborn · Tampa, FLDirectorEnzo A. D'Angelo · Chicago, ILDirectorDerive Ventures GP I, LLC · SAN FRANCISCO, CAExec · DirectorDayna Quanbeck · Carlsbad, CADirectorBrent Saunders · Morris Plains, NJDirectorJacob B. Jones · Raleigh, NCDirectorGordon V. Tucker · Raleigh, NCExec · DirectorSteve Howard · Singapore, U0DirectorSriram Krishnan · Palo Alto, CADirectorAsiff Hirji · Miami, FLDirectorMaximilian Crown · Miami, FLExec · DirectorBrent Saunders · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗